JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB323185

Anti-IRF1 抗体 [EPR28967-56]

Anti-IRF1 antibody [EPR28967-56]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal IRF1 antibody. Suitable for WB and reacts with Human samples.

別名を表示する

Interferon regulatory factor 1, IRF-1, IRF1

2 Images
Western blot - Anti-IRF1 antibody [EPR28967-56] (AB323185)
  • WB

Supplier Data

Western blot - Anti-IRF1 antibody [EPR28967-56] (AB323185)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Performed under reducing conditions.

In Western blot, ab323185 was shown to bind specifically to IRF1. Target of interest was observed at 48 kDa in Wild-type A549 treated with 100 ng/ml IFN-gamma (ab259377) for 4 hours (lane 2) with no signal observed at this size in IRF1 knockout cell line (lane 3-4) (lane 3, knockout cell line ab267042 / knockout cell lysate ab257485).

The identity of the higher MW band at approximately 75 kDa is unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-IRF1 antibody [EPR28967-56] (ab323185) at 1/1000 dilution

Lane 1:

Wild-type A549 (human lung carcinoma epithelial cell)whole cell lysate at 20 µg

Lane 2:

Wild-type A549 treated with 100 ng/ml IFN-gamma (<a href='/products/proteins-peptides/recombinant-human-interferon-gamma-protein-active-ab259377'>ab259377</a>) for 4 hours whole cell lysate at 20 µg

Lane 3:

IRF1 knockout A549 whole cell lysate at 20 µg

Lane 4:

IRF1 knockout A549 treated with 100 ng/ml IFN-gamma (<a href='/products/proteins-peptides/recombinant-human-interferon-gamma-protein-active-ab259377'>ab259377</a>) for 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 48 kDa,36 kDa

false

Exposure time: 62s

Western blot - Anti-IRF1 antibody [EPR28967-56] (AB323185)
  • WB

Supplier Data

Western blot - Anti-IRF1 antibody [EPR28967-56] (AB323185)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The identity of the higher MW bands are unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-IRF1 antibody [EPR28967-56] (ab323185) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HeLa treated with 100ng/ml IFN gamma and 300ng/ml Brefeldin A/BFA for 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 48 kDa,36 kDa

false

Exposure time: 180s

関連する標識済み抗体及び組成の異なる製品 (2)

  • Carrier free

    Anti-IRF1 antibody [EPR28967-56] - BSA and Azide free

  • Carrier free

    Anti-HIV1 p24 antibody [24-2] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR28967-56

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }
style
left-column

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses (PubMed : 15226432, PubMed : 15509808, PubMed : 17516545, PubMed : 17942705, PubMed : 18497060, PubMed : 19404407, PubMed : 19851330, PubMed : 22367195, PubMed : 32385160). Regulates transcription of IFN and IFN-inducible genes, host response to viral and bacterial infections, regulation of many genes expressed during hematopoiesis, inflammation, immune responses and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage (PubMed : 15226432, PubMed : 15509808, PubMed : 17516545, PubMed : 17942705, PubMed : 18497060, PubMed : 19404407, PubMed : 19851330, PubMed : 22367195, PubMed : 7687740). Stimulates both innate and acquired immune responses through the activation of specific target genes and can act as a transcriptional activator and repressor regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters (PubMed : 15226432, PubMed : 15509808, PubMed : 17516545, PubMed : 17942705, PubMed : 18497060, PubMed : 19404407, PubMed : 19851330, PubMed : 21389130, PubMed : 22367195). Has an essentail role in IFNG-dependent immunity to mycobacteria (PubMed : 36736301). Competes with the transcriptional repressor ZBED2 for binding to a common consensus sequence in gene promoters (PubMed : 32385160). Its target genes for transcriptional activation activity include : genes involved in anti-viral response, such as IFN-alpha/beta, RIGI, TNFSF10/TRAIL, ZBP1, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial response, such as GBP2, GBP5 and NOS2/INOS; anti-proliferative response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7, IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA repair, such as POLQ/POLH; MHC class I expression, such as TAP1, PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II expression, such as CIITA; metabolic enzymes, such as ACOD1/IRG1 (PubMed : 15226432, PubMed : 15509808, PubMed : 17516545, PubMed : 17942705, PubMed : 18497060, PubMed : 19404407, PubMed : 19851330, PubMed : 22367195). Represses genes involved in anti-proliferative response, such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune response, such as FOXP3, IL4, ANXA2 and TLR4 (PubMed : 18641303, PubMed : 22200613). Stimulates p53/TP53-dependent transcription through enhanced recruitment of EP300 leading to increased acetylation of p53/TP53 (PubMed : 15509808, PubMed : 18084608). Plays an important role in immune response directly affecting NK maturation and activity, macrophage production of IL12, Th1 development and maturation of CD8+ T-cells (PubMed : 11244049, PubMed : 11846971, PubMed : 11846974, PubMed : 16932750). Also implicated in the differentiation and maturation of dendritic cells and in the suppression of regulatory T (Treg) cells development (PubMed : 11244049, PubMed : 11846971, PubMed : 11846974, PubMed : 16932750). Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells (PubMed : 20049431).
See full target information IRF1
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com